Life Sciences

• Foley Hoag Represents Dogma Therapeutics in Sale of Its Oral PCSK9 Inhibitor Program to AstraZeneca

  September 17, 2020

• Foley Hoag Represents Glympse Bio in $46.7M Series B Financing

  July 23, 2020

• Foley Hoag Secures Court of Appeals Win for Dana-Farber Cancer Institute on Inventorship of Groundbreaking Cancer Immunotherapy Patents

  July 16, 2020

• Foley Hoag Advises RTW Investments and Ji Xing Pharmaceuticals on IP Matters in Royalty Monetization and Strategic Licensing Agreement with Cytokinetics for Up to $450 Million in Upfront and Milestone Payments

  July 15, 2020

• Foley Hoag Represents Pear Therapeutics, Inc. in Closing $50M Loan Transaction with Perceptive Advisors

  July 10, 2020

• Foley Hoag Represents GreenLight Biosciences in Closing $102 Million Series D Funding Round

  June 22, 2020

• Foley Hoag, Four Partners Recognized by Managing Intellectual Property Magazine

  May 11, 2020

• Foley Hoag Advises on Offerings of Senior Unsecured Notes for Biogen and Entegris

  May 1, 2020

• Foley Hoag Attorneys David Geiger and Seth Jaffe Selected for JD Supra 2020 Readers Choice Awards

  April 29, 2020

• Foley Hoag Forms Coronavirus (COVID-19) Task Force

  March 13, 2020